Departments of 1Physiology, 2Pathology and 3Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia *Corresponding Author’s e-mail: mtalhariri@iau.edu.sa العكرب يعدل من وسائط االلتهاب وحيسن الرتكيب النسيجي لذكور اجلرذان املصابة بالتهاب البنكرياس احلاد احملدث بواسطة األرجينني حممد طه احلريري، ثروت جمال الدين، طارق ها�شم، �شاهان�س �شاثوث، عبد اهلل ال�شويد abstract: Objectives: This study aimed to determine the effects of propolis on immune mediators and tissue histopathology in rats with L-arginine-induced acute pancreatitis (AP). Methods: This study was conducted at Imam Abdulrahman Bin Faisal University, Dammam, Saudia Arabia between September and November 2017. A total of 24 male albino Wistar rats were divided into three equal groups. Group one was the negative control, group two was the positive control (L-arginine-induced AP) and group three received treatment (L-arginine- induced AP and propolis). The rats in group three were treated with 100 mg/kg propolis for seven days after AP induction. Pancreatic tissue was evaluated histologically and levels of interleukin (IL)-6, IL-22 and IL-1β and tumour necrosis factor-alpha (TNF-α) were measured. Results: Propolis reduced the quanitity of proinflammatory molecules (TNF-α, IL-1β and IL-6) in group three compared to group two, significantly increased the overall anti- inflammatory effect of IL-22 (P <0.005) and reduced interstitial inflammation and neutrophil cell infiltration of the pancreatic tissues. Conclusion: Propolis may exert a therapeutic effect in AP. Further studies are required to demonstrate the mechanisms of propolis in AP. Keywords: Propolis; Arginine; Pancreatitis; Interleukins; Cytokinesis; Rats; Saudi Arabia. والتغريات الدم، يف البيوكيميائية والوا�شمات املناعة و�شائط على العكرب فعالية حتديد الدرا�شة هذه من الهدف كان الهدف: امللخ�ص: الن�شيجية يف اجلرذان امل�شابة بالتهاب البنكريا�س احلاد. الطريقة: اأجريت هذه الدرا�شة يف جامعة االإمام عبد الرحمن بن في�شل، الدمام، اململكة العربية ال�شعودية بني �شهري �شبتمرب ونوفمرب 2017. مت تق�شيم 42 من ذكور اجلرذان املهق اإىل 3 جمموعات مت�شاوية. املجموعة االأوىل: ال�شابطة ال�شلبية؛ املجموعة الثانية: ال�شابطة االإيجابية وهي امل�شابة بالتهاب البنكريا�س احلاد املحدث بوا�شطة االرجنني؛ املجموعة الثالثة: جمموعة م�شابة بالتهاب البنكريا�س و مت معاجلتها بالعكرب )100 جمم/كجم/ملدة 7 اأيام(. يف نهاية فرتة البحث متت درا�شة اأن�شجة البنكريا�س ومت قيا�س م�شتويات االإنرتلوكني )6، 22، 1ب( وعامل نخر الورم األفا. النتائج: اأظهرت النتائج اأن العكرب قد قلل من كمية جزيئات ما قبل االلتهابات وهي االإنرتلوكني )6، 1ب(و من م�شتوى عامل نخر الورم األفا مقارنة باملجموعة الثانية، وزاد ب�شكل كبري من التاأثري امل�شاد لاللتهابات بوا�شطة اإنرتلوكني 22 عند داللة اإح�شائية تعادل )P >0.005( اإ�شافة اإىل اأن العكرب قد قلل ب�شكل ملحوظ من االلتهاب الن�شيجي للبنكريا�س. اخلال�صة: اأظهرت الدرا�شة اأن للعكرب تاأثريا عالجيا يف التهاب البنكريا�س احلاد، االأمر الذي يفتح االأبواب الإجراء العديد من االأبحاث يف هذا اخل�شو�س الإثبات اآليات عمل العكرب يف عالج مثل هذه احلاالت. الكلمات املفتاحية: العكرب؛ اأرجينني؛ التهاب البنكريا�س؛ اإنرتلوكني؛ �شايتوكني؛ اجلرذان؛ العربية ال�شعودية. Propolis Modulates Inflammatory Mediators and Improves Histopathology in Male Rats with L-arginine-induced Acute Pancreatitis *Mohammed T. Al-Hariri,1 Tharwat G. Eldin,1 Tarek Hashim,2 Shahanas Chathoth,3 Abdullah Alswied1 Sultan Qaboos University Med J, May 2019, Vol. 19, Iss. 2, pp. e103–107, Epub. 8 Sep 19 Submitted 2 Oct 18 Revision Req. 3 Dec 18; Revision Recd. 26 Dec 18 Accepted 17 Jan 19 Advances in Knowledge - The present study identifies the anti-pancreatitis effect of propolis. - The anti-pancreatitis effect takes potential inflammatory and proinflammatory pathways. Application to patient care - Propolis minimised inflammatory response and pancreatic tissue damage. - Propolis should be considered an effective and promising natural compound for managing acute pancreatitis. Pancreatitis is a major gastrointestinal problem worldwide.1 Despite the development of new therapeutic and diagnostic approaches, the clinical course of acute pancreatitis (AP) is assoc- iated with significant morbidity and a high mortality rate.2,3 Experimental studies focused on the molecular pathway, including proinflammatory cytokines, are shedding light on the pathophysiologic mechanisms of AP. Increased levels of proinflammatory cytokines—such as interleukin (IL)-1, IL-6 and tumour necrosis factor- This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License. https://doi.org/10.18295/squmj.2019.19.02.004 clinical & basic research https://creativecommons.org/licenses/by-nd/4.0/ Propolis Modulates Inflammatory Mediators and Improves Histopathology in Male Rats with L-arginine-induced Acute Pancreatitis e104 | SQU Medical Journal, May 2019, Volume 19, Issue 2 alpha (TNF-α)—aggravate AP by increasing vascular permeability.4-6 Propolis is a natural resinous compound collected by bees from the gum of various plants and converted through salivary secretions to beeswax. Propolis has attr- acted global attention for its wide range of pharmacol- ogical and biological properties, making propolis a poten- tially promising therapeutic agent.7 The efficacy of pro- polis depends mainly on the presence of flavonoids, primarily caffeic acid phenethyl ester (CAPE), which pro- vide an anti-inflammatory effect.8 Future studies should focus on standardising the therapeutic applications of propolis.9 Many studies have shown that the anti-inflamm- atory activity of propolis and/or its compounds inhibit the activation of cyclooxygenase (COX)-2 gene expression, suppress enzyme activities of COX-1 and COX-2 and inhibit the release of arachidonic acid from cell mem- branes.10,11 Galangin, a propolis-associated flavonoid, has been shown to decrease prostaglandin E2 release, inhibit lipoxygenase, COX and the expression of the inducible isoform of COX-2.12 This study aimed to determine the effects of propolis on immune mediators and tissue histopathology of rats with L-arginine-induced AP. Methods This study was conducted at Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia from September to November 2017. A total of 24 male albino Wistar rats weighing 150–250 g were obtained from the university’s animal house for this study. All rats were maintained in a room at a constant temperature of 22 ± 1°C with 12 hour light/dark cycles and had free access to standard laboratory food pellets and water. The rats were equally divided into three groups. Group one was the untreated negative control group, group two consisted of the positive controls and group three was the experimental treatment group. Group two and three were injected with L-arginine to induce AP. Two intraperitoneal (IP) injections of L-arginine (Sigma-Aldrich Chemical, Merck KGaA, Darmstadt, Germany) at a dose of 250 mg/100 g of body weight (BW) prepared in isotonic saline (20% 0.15 M sodium chloride) were administered at a one-hour interval to induce AP.13 The rats in group three were treated orally with Brazilian green propolis alcohol extract (Uniflora Apicultores Associados Ltda, Olímpia, Brazil) 100 mg/kg of BW after two hours of L-arginine injection and daily for seven days.14 This dose has previously been shown to be anti-inflammatory.15 AP was diagnosed clinically as rats became sluggish and lethargic. The condition was most severe 72 hours after the L-arginine-injections and was confirmed by histopathological examination.16 The treatment regimens were stopped after seven days and 12 hours before the rats were anaesthetised with an IP injection of ketamine (50 mg/kg of BW; Alfasan International BV, Woerden, the Netherlands). Rats were euthanised and blood was collected from the abdominal aorta by means of a vacutainer.17 Anti- inflammatory cytokines (IL-1β, IL-6, TNF-α and IL- 22) were assessed by enzyme-linked immunosorbent assay (ELISA). The IL-22 ELISA Kit (R&D Systems, Minneapolis, Minnesota, USA) and all other cytokine assays (Bio-Rad Laboratories Inc., Hercules, California, USA) were quantified in accordance with the manufact- urers’ guidelines and instructions.18,19 Pancreatic tissues were fixed in a 10% formal- dehyde solution for 48 hours, embedded in paraffin wax and sectioned. The sections were stained with haema- toxylin and eosin and evaluated under a light microscope to detect inflammatory manifestations, including oedema, leukocyte infiltration, parenchymal necrosis and haemo- rrhage in the pancreatic tissue. The general morphology and histological features were evaluated with a BX51 photomicroscope (Olympus Corporation, Tokyo, Japan).20 Histopathologic scoring for AP included assess- ment of inflammatory cell infiltration, oedema and acinar degenerative changes. The inflammatory cells were counted in five high power field (HPF) × 400 images and the mean number of cells was calculated and rated. Fewer than 50 inflammatory cells/HPF was rated 1+ (mild), 50–100 inflammatory cells/HPF was rated 2+ (moderate) and >100 inflammatory cells/HPF was rated 3+ (severe). Statistical analysis was performed using Statistical Package of Social Science (SPSS), Version 21 (IBM Corp., Armonk, New York, USA). Data are presented as means ± standard error of the mean. One-way analysis of variance followed by Tukey’s multiple comparison post-hoc test was used to compare the means. Statistical significance was set at P <0.05. All experiments were performed in accordance with the recommendations of the national guidelines for the care and handling of laboratory animals. The experimental protocol was approved by the Local Animal Ethics Committee (IRB 2015-01-185). Results Serum proinflammatory cytokines (IL-1β, IL-6 and TNF-α) and anti-inflammatory IL-22 in the three studied groups are shown in Table 1. Injecting two doses of L-arginine induced an increase in proinflammatory measurements and a decrease in the measured anti- inflammatory cytokine concentration in group two. Moreover, pathohistological features of AP were present. Mohammed T. Al-Hariri, Tharwat G. Eldin, Tarek Hashim, Shahanas Chathoth and Abdullah Alswied Clinical and Basic Research | e105 The mean serum concentration of IL-1β was signif- icantly higher in group two than group one (P <0.005). Group two also had significantly higher TNF-α and IL-6 than groups one and three (P <0.005 and P <0.001 each). The mean serum level of IL-22 for the propolis-treated group increased significantly compared to groups one and two (P <0.005 and P <0.001, respectively) [Table 1]. Group two was rated as 3+ and group three was rated at 2+. While regular pancreas morphology was observed in the tissues of rats in group one [Figure 1], severe degrees of inflammatory cell infiltration, pancreatic tissue necrosis, haemorrhage and parenchymal degen- erative changes were observed in the tissues of rats in group two compared with the other groups (P <0.05) [Figure 2]. However, treatment with propolis in group three significantly decreased the degree of cellular infiltration, interstitial oedema, acinar cell necrosis and parenchymal degenerative changes compared to group two (P <0.05) [Figure 3]. Discussion Previous studies have used experimental AP induced by L-arginine to study the effect of various therapeutic agents and the pathophysiologic mechanisms of the disease.21 The present study aimed to determine the effects of propolis on immune mediators and tissue histopathology in rats with AP. The effect of propolis was evidenced by a decrease in proinflammatory cytokines (TNF-α, IL-1β and IL-6) and a significant increase in the level of anti-inflammatory IL-22 to levels close to that of the negative controls. Several studies have focused on the pathogenesis of AP.2,6 Overproduction of inflammatory mediators, including TNF-α, IL-1β, IL-6 and IL-8, was found to play an important role in the pathogenesis of AP.22 Table 1: Serum analysis of proinflammatory (interleukin [IL]-1β, IL-6 and tumour necrosis factor-alpha) and anti- inflammatory (IL-22) cytokine in three rat groups Group Mean ± SEM I (negative control) II (positive control) III (propolis- treated group) IL-1β in pg/mL 36.39 ± 3.07 116.13 ± 4.28* 41.43 ± 4.01 IL-6 in pg/mL 39.02 ± 3.13 85.44 ± 3.39*‡ 45.21 ± 2.05 TNF-α in pg/mL 59.74 ± 1.40 96.91 ± 2.51*‡ 48.83 ± 1.51 IL-22 in pg/mL 0.19 ± 0.020 0.15 ± 0.023 0.30 ± 0.056*† SEM = standard error of mean; IL = interleukin; TNF-α = tumour necr- osis factor-alpha. *significantly different from group one (P <0.005); †significantly different from group two (P <0.001); ‡significantly different from group three (P <0.001). Figure 1: Haematoxylin and eosin stain of pancreatic tissue from group one at x200 maginification showing normal, unremarkable pancreatic tissue in both exocrine (Exo) and endocrine parts (Islet). Figure 3: Haematoxylin and eosin stain of pancreatic tissue from group three at x400 maginification showing moderate interstitial inflammation and neutrophil cell infiltration of the pancreatic tissue (arrow). Figure 2: Haematoxylin and eosin stain of pancreatic tissue from group two at x200 maginification showing significant severe interstitial inflammation, oedema with mixed mononuclear inflammatory cells (arrows) and neut- rophils. The pancreatic acini show moderate parenchymal degenerative changes (arrowheads). Propolis Modulates Inflammatory Mediators and Improves Histopathology in Male Rats with L-arginine-induced Acute Pancreatitis e106 | SQU Medical Journal, May 2019, Volume 19, Issue 2 In the present study, propolis significantly reduced the total pathologic score and the extent of oedema, most likely due to the anti-inflammatory action of propolis and/or its active compounds.23 These results agree with those of previous studies from different AP models.24 Interestingly, an important and novel result of this study was the finding that propolis significantly increased levels of IL-22, which had not been tested in previous studies. The anti-inflammatory activities of propolis are still not fully understood. Pooran et al. suggested that propolis has an anti-inflammatory effect as it inhibits the release of histamine, prostaglandins and leukotrienes.22 Another study reported that the anti-inflammatory properties of propolis are due to CAPE.25 CAPE exerts its anti-inflammatory actions by suppressing the inflammatory enzyme activities of COX-1 and COX-2 and inhibiting the release of arachidonic acid from cell membranes.26 In the current study, there was non-significant minimal change in IL-22 levels between groups one and two. The increase of IL-22 in only group three could be via the signal transducer and activator of transcription (STAT) 3 signaling pathway in which exogenous recombinant IL-22 protected mice from L-arginine- induced AP.27 The favourable effect of IL-22 is thought to depend on the extent of AP inflammation. In mild cases of induced AP, administration of exogenous IL-22 successfully aborted disease development.28 Furthermore, over-expressed animal models of IL-22 were resistant to AP development.29 Xue et al. was reported that the administration of the anti-IL-22 anti- body, to block the receptors, endogenously aggravated pancreatic injury which supports the essential role of IL-22.30 Collectively, these findings strongly suggest that IL-22 plays a vital role in AP prevention. Further- more, IL-22 may mediate a protective effect against L-arginine-induced AP via activation of the STAT3 signaling pathway, which can suppress apoptosis by inducing downstream genes, including Bcl-xL and Bcl-2.31 While some studies have discussed several promising mechanisms, the proposed therapeutic effect of propolis needs further investigation to better characterise the mechanism by which it exerts the observed therapeutic effect.26,32 The push-and-pull between the anti-inflamm- atory and proinflammatory cytokines are believed to determine the outcome of AP.33,34 Immune-modifying therapeutic approaches have been used for many inflammatory conditions with the aim of promoting the release of the anti-inflammatory cytokines and/or hindering the release of the inflammatory cytokines. Recently, Lattanzi et al. provided evidence for the potential contributions of the inflammatory reaction and/or inflammatory-induced oxidative stress in the aetiopathogenesis of several complicated disorders such as acute stroke and degenerative and secondary dementia.35 The anti-inflammatory properties of propolis could suggest novel pathophysiology-oriented treat- ment options in the management of various medical conditions where inflammation plays a pivotal role in the development and progression of tissue damage.36 Conclusion Propolis attenuated the severity of inflammation of the pancreatic tissues of rats with L-arginine-induced AP. Therefore, propolis could be investigated as a potential treatment for many inflammatory conditions in humans. c o n f l i c t o f i n t e r e s t The authors declare no conflicts of interest. f u n d i n g Financial support was received from King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (M S 302-35). References 1. Goulden MR. The pain of chronic pancreatitis: a persistent clinical challenge. British journal of pain 2013; 7:8-22. https://doi.org/10.1 177/2049463713479230. 2. Bülbüller N, Doğru O, Umaç H, Gürsu F, Akpolat N. [The effects of melatonin and pentoxiphylline on L-arginine induced acute pancreatitis]. Ulus Travma Acil Cerrahi Derg 2005; 11:108–14. 3. Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101:2379–400. https://doi.org/10.1111/j.1572-0241.2006.00856.x. 4. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997; 100:1853–62. https:// doi.org/10.1172/JCI119714. 5. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pan- creatitis. Gastroenterology 1996; 110:639–42. https://doi.org/10.10 53/gast.1996.v110.agast960639. 6. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998; 275:G1402–14. https://doi.org/1 0.1152/ajpgi.1998.275.6.G1402. 7. Greenaway W, Scaysbrook T, Whatley FR. The composition and plant origins of propolis: A report of work at Oxford. Bee World 1990; 71:107–18. https://doi.org/10.1080/0005772X.1990.1109 9047. 8. Okutan H, Ozcelik N, Yilmaz HR, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005; 38:191–6. https://doi. org/10.1016/j.clinbiochem.2004.10.003. 9. Al-Hariri MT, Eldin TAG, Al-Harb MM. Protective effect and potential mechanisms of propolis on streptozotocin-induced diabetic rats. J Taibah Univ Med Sci 2016; 11:7–12. https://doi. org/10.1016/j.jtumed.2015.11.002. https://doi.org/10.1177/2049463713479230 https://doi.org/10.1177/2049463713479230 https://doi.org/10.1111/j.1572-0241.2006.00856.x https://doi.org/10.1172/JCI119714 https://doi.org/10.1172/JCI119714 https://doi.org/10.1053/gast.1996.v110.agast960639 https://doi.org/10.1053/gast.1996.v110.agast960639 https://doi.org/10.1152/ajpgi.1998.275.6.G1402 https://doi.org/10.1152/ajpgi.1998.275.6.G1402 https://doi.org/10.1080/0005772X.1990.11099047 https://doi.org/10.1080/0005772X.1990.11099047 https://doi.org/10.1016/j.clinbiochem.2004.10.003 https://doi.org/10.1016/j.clinbiochem.2004.10.003 https://doi.org/10.1016/j.jtumed.2015.11.002 https://doi.org/10.1016/j.jtumed.2015.11.002 Mohammed T. Al-Hariri, Tharwat G. Eldin, Tarek Hashim, Shahanas Chathoth and Abdullah Alswied Clinical and Basic Research | e107 10. Rossi A, Ligresti A, Longo R, Russo A, Borrelli F, Sautebin L. The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages. Phytomedicine 2002; 9(6):530-5. https://doi.org/10.1078/09447110260573164. 11. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygen- ase-2 in human oral epithelial cells and in a rat model of inflamm- ation. Cancer research 1999; 59:2347-52. 12. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 1999; 59:2347–52. 13. Dawra R, Saluja AK. L-arginine-induced experimental acute pancreatitis. Pancreapedia: Exocrine Pancreas Knowl Base 2012. https://doi.org/10.3998/panc.2012.6. 14. Kaur J, Sidhu S, Chopra K, Khan MU. Calendula officinalis ameliorates l-arginine induced acute necrotizing pancreatitis in rats. Pharm Biol 2016; 54:2951–9. https://doi.org/10.1080/138802 09.2016.1195848. 15. Park EH, Kahng JH. Suppressive effects of propolis in rat adjuvant arthritis. Arch Pharm Res 1999; 22:554–8. https://doi.org/10.10 07/BF02975325. 16. Sharma S, Rana SV, Rana S, Bhasin DK, Nada R, Malhotra S. Severe chronic pancreatitis due to recurrent acute injury: Non- invasive chronic pancreatitis model of rat. JOP. J Pancreas (Online) 2017; 18:107–20. 17. Al-Hariri M, Eldin TG, Abu-Hozaifa B, Elnour A. Glycemic control and anti-osteopathic effect of propolis in diabetic rats. Diabetes Metab Syndr Obes 2011; 4:377–84. https://doi.org/10.2147/DM SO.S24159. 18. Frossard J L, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001; 164:162–70. https://doi.org/10.1164/ajrcc m.164.1.2008026. 19. Shukla R, Santoro J, Bender FC, Laterza OF. Quantitative deter- mination of human interleukin 22 (IL-22) in serum using Sing- ulex-Erenna® technology. J Immunol Methods 2013; 390:30–4. https://doi.org/10.1016/j.jim.2013.01.002. 20. Bulut NE, Özkan E, Ekinci O, Dulundu E, Topaloğlu Ü, Şehirli AÖ, et al. Beneficial effects of alpha lipoic acid on cerulein-induced experimental acute pancreatitis in rats. Ulus Travma Acil Cerrahi Derg 2011; 17:383–9. https://doi.org/10.5505/tjtes.2011.99835. 21. Rakonczay Z Jr, Hegyi P, Dósa S, Iványi B, Jármay K, Biczó G, et al. A new severe cute necrotizing pancreatitis model ind- uced by L-ornithine in rats. Crit Care Med 2008; 36:2117–27. https://doi.org/10.1097/CCM.0b013e31817d7f5c. 22. Pooran N, Indaram A, Singh P, Bank S. Cytokines (IL-6, IL-8, TNF): Early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol 2003; 37:263–6. https://doi.org/10.1097/0 0004836-200309000-00013. 23. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. Phytochemical compounds involved in the anti-infla- mmatory effect of propolis extract. Fitoterapia 2002; 73:S53–63. https://doi.org/10.1016/S0367-326X(02)00191-0. 24. Büyükberber M, Savaş M, Bağci C, Koruk M, Gülşen MT, Tutar E, et al. The beneficial effect of propolis on cerulein-ind- uced experimental acute pancreatitis in rats. Turk J Gastro- enterol 2009; 20:122–8. 25. Hu F, Hepburn HR, Li Y, Chen M, Radloff SE, Daya S. Effects of ethanol and water extracts of propolis (bee glue) on acute infla- mmatory animal models. J Ethnopharmacol 2005; 100:276–83. https://doi.org/10.1016/j.jep.2005.02.044. 26. Rossi A, Longo R, Russo A, Borrelli F, Sautebin L. The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase activity by propolis. Fitoterapia 2002; 73:S30–7. https://doi.org/10.1016/S0367-326X(02)00188-0. 27. Qiao YY, Liu XQ, Xu CQ, Zhang Z, Xu HW. Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice. World J Gastroenterol 2016; 22:5023–32. https://doi. org/10.3748/wjg.v22.i21.5023. 28. Feng D, Park O, Radaeva S, Wang H, Yin S, Kong X, et al. Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway. Int J Biol Sci 2012; 8:249–57. https://doi.org/10.7150/ijbs.3967. 29. Huan C, Kim D, Ou P, Alfonso A, Stanek A. Mechanisms of interleukin-22's beneficial effects in acute pancreatitis. World J Gastrointest Pathophysiol 2016; 7:108–16. https://doi.org/10.4 291/wjgp.v7.i1.108. 30. Xue J, Nguyen DT, Habtezion A. Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis. Gastroenterology 2012; 143:1670–80. https://doi.org/10.1053/j.gastro.2012.08.051. 31. Liu XQ, Qiao YY, Xu CQ, Zhu ST, Xu HW. Protective effects of interleukin-22 on severe acute pancreatitis-associated kidney injury in mice. Austin Intern Med 2017; 2:1016. 32. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329:21–4. https://doi.org/10.1016/0014-5793(93)80184-V. 33. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. Phytochemical compounds involved in the anti-infla- mmatory effect of propolis extract. Fitoterapia 2002; 73:S53–63. https://doi.org/10.1016/S0367-326X(02)00191-0. 34. Singh VK, Bollen TL, Wu BU, Repas K, Maurer R, Yu S, et al. An assessment of the severity of interstitial pancreatitis. Clin Gastro- enterol Hepatol 2011; 9:1098–103. https://doi.org/10.1016/j.c gh.2011.08.026. 35. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil- to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget 2017; 8:57489–94. https://doi.org/10.18632/oncotarget.15423. 36. Lattanzi S, Carbonari L, Pagliariccio G, Bartolini M, Cagnetti C, Viticchi G, et al. Neurocognitive functioning and cerebrovasc- ular reactivity after carotid endarterectomy. Neurology 2018; 90:e307–15. https://doi.org/10.1212/WNL.0000000000004862. https://doi.org/10.1078/09447110260573164 https://doi.org/10.3998/panc.2012.6 https://doi.org/10.1080/13880209.2016.1195848 https://doi.org/10.1080/13880209.2016.1195848 https://doi.org/10.1007/BF02975325 https://doi.org/10.1007/BF02975325 https://doi.org/10.2147/DMSO.S24159 https://doi.org/10.2147/DMSO.S24159 https://doi.org/10.1164/ajrccm.164.1.2008026 https://doi.org/10.1164/ajrccm.164.1.2008026 https://doi.org/10.1016/j.jim.2013.01.002 https://doi.org/10.5505/tjtes.2011.99835 https://doi.org/10.1097/CCM.0b013e31817d7f5c https://doi.org/10.1097/00004836-200309000-00013 https://doi.org/10.1097/00004836-200309000-00013 https://doi.org/10.1016/S0367-326X%2802%2900191-0 https://doi.org/10.1016/j.jep.2005.02.044 https://doi.org/10.1016/S0367-326X%2802%2900188-0 https://doi.org/10.3748/wjg.v22.i21.5023 https://doi.org/10.3748/wjg.v22.i21.5023 https://doi.org/10.7150/ijbs.3967 https://doi.org/10.4291/wjgp.v7.i1.108 https://doi.org/10.4291/wjgp.v7.i1.108 https://doi.org/10.1053/j.gastro.2012.08.051 https://doi.org/10.1016/0014-5793%2893%2980184-V https://doi.org/10.1016/S0367-326X%2802%2900191-0 https://doi.org/10.1016/j.cgh.2011.08.026 https://doi.org/10.1016/j.cgh.2011.08.026 https://doi.org/10.18632/oncotarget.15423 https://doi.org/10.1212/WNL.0000000000004862